Intrinsiqq
Boundless Bio, Inc. logo

Boundless Bio, Inc. Insider Trading

BOLD

Compare
Last 12 months

No open-market buying or selling by insiders.

The last open-market buy by an executive or director was in Apr 2024.

Net open-market
$0
0 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
0 / 0
executives and directors
Last open-market buy
Apr 2024
Apr 2, 2024

Get an email when BOLD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 18 – 20
    Kevin Tang
    Large holder · bought 103,612 at avg $2.36
    244K
    3.4% of stake
  • Nov 13 – 17
    Kevin Tang
    Large holder · bought 13,812 at avg $2.40
    33K
    0.5% of stake
  • Nov 6 – 10
    Kevin Tang
    Large holder · bought 1,949 at avg $2.40
    5K
    <0.1% of stake
  • Nov 3 – 5
    Kevin Tang
    Large holder · bought 11,162 at avg $2.40
    27K
    0.4% of stake
  • Oct 27
    Kevin Tang
    Large holder · bought 10,707 at $2.40
    26K
    0.4% of stake
  • Oct 22 – 26
    Kevin Tang
    Large holder · bought 21,640 at avg $2.39
    52K
    0.7% of stake
  • Oct 16 – 20
    Kevin Tang
    Large holder · bought 149,474 at avg $2.34
    350K
    5.3% of stake
  • Aug 26No plan
    Tang Capital Management LLC
    Large holder · sold 18,300 at $2.97
    54K
    0.6% of stake
  • Jul 17 – 21
    Kevin Tang
    Large holder · bought 4,863 at avg $2.44
    12K
    0.2% of stake
  • Jul 14 – 16
    Kevin Tang
    Large holder · bought 63,969 at avg $2.43
    156K
    2.3% of stake
  • Jul 9 – 13
    Kevin Tang
    Large holder · bought 91,585 at avg $2.42
    222K
    3.4% of stake
  • Jul 6 – 8
    Kevin Tang
    Large holder · bought 57,210 at avg $2.48
    142K
    2.2% of stake
  • Jun 30 – Jul 2
    Kevin Tang
    Large holder · bought 107,463 at avg $2.50
    269K
    4.2% of stake
  • Jul 1No plan
    Steven Gillis
    Large holder · sold 16,000 at $2.49
    40K
    1.3% of stake
  • Jul 1No plan
    Arch Venture Partners IX, L.p.
    Large holder · sold 16,000 at $2.49
    40K
    1.9% of stake
  • Jun 25 – 29
    Kevin Tang
    Large holder · bought 286,333 at avg $2.50
    715K
    13% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BOLD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BOLD

CompareIntrinsic value
UPBUpstream Bio, Inc.
$1.59-20.50%21
OVIDOvid Therapeutics Inc.
$2.20-5.98%10
LQDALiquidia Corporation
$54.43-3.88%63
PCRXPacira BioSciences Inc.
$36.48+0.00%61
SRPTSarepta Therapeutics Inc.
$13.33-5.93%58
ETONEton Pharmaceuticals Inc.
$60.85-0.83%75
ZBIOZenas BioPharma, Inc.
$23.85-4.75%10
AGIOAgios Pharmaceuticals Inc.
$27.60-4.03%40

Spot a number that looks wrong? Check it in BOLD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BOLD

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.